November 25, 2016
MSD will take on the distribution of Bayer Yakuhin’s pulmonary arterial hypertension (PAH) treatment Adempas (riociguat) from January next year, the two companies said on November 24. Under a business collaboration deal signed on November 22, MSD will solely distribute...read more